Crown MycoResin Biotech, Inc. is led by a forward-thinking leadership team committed to advancing agarwood biotechnology, sustainable agroforestry, and inclusive agribusiness models. The company’s leadership combines scientific innovation, operational discipline, and strategic market development to drive long-term value across the agarwood industry.
Emmanuelle Rae E. Putong, President
As President of CMBI, Emmanuelle Rae E. Putong provides overall strategic direction and executive leadership. She spearheads the development of the company’s biotic, abiotic, and dual induction technologies, including the BarIno™ product line.
She is instrumental in:
- Designing the Contract Inoculation Agreement (CIA) framework
- Leading product innovation and protocol standardization
- Building plantation partnerships and investor networks
- Driving market linkage and offtake strategies
Her leadership emphasizes scientific precision, sustainability, and scalable business models, positioning CMBI as a key player in the agarwood biotechnology sector.
Leadership Approach
CMBI’s leadership philosophy is anchored on:
- Innovation-Driven Growth
Continuous advancement in microbial, chemical, and hybrid induction systems - Field-to-Market Integration
Aligning plantation operations with global agarwood demand - Data-Driven Decision Making
Utilizing DBH-based systems, monitoring protocols, and yield analytics - Farmer-Centric Development
Ensuring accessibility of technology and equitable participation
Organizational Direction
The leadership team guides CMBI toward:
- Establishing industry standards in agarwood resin induction
- Expanding contract inoculation services across regions
- Strengthening buyer networks in international markets
- Integrating sustainability and traceability systems
Leadership Statement
“We lead with science, grow with integrity, and scale with purpose—building a sustainable and inclusive future for agarwood.”